000 01791 a2200541 4500
005 20250516125444.0
264 0 _c20130624
008 201306s 0 0 eng d
022 _a1095-6859
024 7 _a10.1016/j.ygyno.2012.12.012
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, Chi-Hau
245 0 0 _aMUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
_h[electronic resource]
260 _bGynecologic oncology
_cMar 2013
300 _a560-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Growth Processes
_xphysiology
650 0 4 _aCell Line, Tumor
650 0 4 _aDisease Models, Animal
650 0 4 _aEndometrial Neoplasms
_xgenetics
650 0 4 _aEpidermal Growth Factor
_xgenetics
650 0 4 _aErbB Receptors
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, SCID
650 0 4 _aMiddle Aged
650 0 4 _aMucins
_xbiosynthesis
650 0 4 _aNeoplasm Staging
650 0 4 _aPhenotype
650 0 4 _aPhosphorylation
650 0 4 _aPrognosis
650 0 4 _aSTAT3 Transcription Factor
_xgenetics
650 0 4 _aSignal Transduction
650 0 4 _aTransfection
700 1 _aWang, Shu-Wei
700 1 _aChen, Chih-Wei
700 1 _aHuang, Miao-Ruei
700 1 _aHung, Ji-Shiang
700 1 _aHuang, Hsiu-Chin
700 1 _aLin, Ho-Hsiung
700 1 _aChen, Ruey-Jien
700 1 _aShyu, Ming-Kwang
700 1 _aHuang, Min-Chuan
773 0 _tGynecologic oncology
_gvol. 128
_gno. 3
_gp. 560-7
856 4 0 _uhttps://doi.org/10.1016/j.ygyno.2012.12.012
_zAvailable from publisher's website
999 _c22367052
_d22367052